Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Death of a parent during childhood is associated with greater mortality in early adulthood

  • The 92 percent clean plate club: You're not alone in eating everything on your plate

  • Wide-faced men negotiate nearly ,200 larger signing bonus

  • How stress hormones promote brain's building of negative memories

  • Why do challenging tasks make consumers believe drugs wear off faster?

  • Empathy or justice: What makes consumers donate more to charity?

  • I?ll have what he's having? How consumers make choices about new products

  • Retail pricing strategies: Do consumers prefer Deep Discounts or Everyday Low Prices?

  • Clients of violence interventional advocacy program find experience supportive

  • Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders

  •